report in May on the pandemic, Mr. Rouz said Covid-19 might have started as a “globalist conspiracy to establish sweeping population control,” one that had ties to Bill and Hillary Clinton, the billionaires George Soros and Bill Gates, and “the deep state.”

Ms. Britton, the former OAN producer, recalled checking a website that Mr. Rouz had cited to back some of his reporting. “It literally took me to this chat room where it’s just conservatives commenting toward each other,” she said.

In an email to staff last month, Ms. Oakley, the news director, warned producers against ignoring or playing down Mr. Rouz’s work. “His stories should be considered ‘H stories’ and treated as such,” she wrote in the email, which The Times reviewed. “These stories are often slugged and copy-edited by ME as per Mr. H’s instructions.”

OAN’s online audience is significant, with nearly 1.5 million subscribers to its YouTube channel. One of its most popular videos, with about 1.5 million views since it went online Nov. 24, criticized Dominion Voting Systems, the election technology company whose equipment was used in more than two dozen states last year, including several won by Mr. Trump. Hosted by the OAN White House correspondent, Chanel Rion, the video shows a man who said he had infiltrated Dominion and heard company executives say they would “make sure” Mr. Trump lost.

Dominion has sued Fox News and two of Mr. Trump’s lawyers, Rudolph W. Giuliani and Sidney Powell, accusing them of making or promoting defamatory claims. A lawyer for Dominion, who did not reply to requests for comment, has said the company is considering further legal action.

Mr. Golingan, the producer, said some OAN employees had hoped Dominion would sue the channel. “A lot of people said, ‘This is insane, and maybe if they sue us, we’ll stop putting stories like this out,’” he said.

Weeks after Dominion filed its first defamation suits, OAN broadcast a two-hour video in which the chief executive of MyPillow, Mike Lindell, made his case that widespread voter fraud had occurred. YouTube removed the video the day it was posted, saying it violated the platform’s election integrity policy. Last month, an OAN report described Dominion’s “voting machines” as “notorious.”

Two of the current and former employees interviewed for this article — Dan Ball, a talk-show host, and Neil W. McCabe, a former reporter — described OAN’s coverage as unbiased. Mr. McCabe, who now writes for The Tennessee Star, said the network gave a “voice to people that are just not covered.”

Susan Beachy contributed research.

View Source

Ontario Police’s Sweeping New Powers on Covid Draw Criticism

Ontario, Canada’s most populous province, has extended and expanded its stay-at-home orders and given the police sweeping new powers to enforce the mandates in an effort to curb rising case numbers and hospitalizations.

The police will now be able to stop and question people, including those in vehicles, to make sure that their trips outside home are essential. Residents, who are not permitted to gather with members outside their household with some exceptions, could face fines if they do not comply with the new orders. The Ontario government is also expected to restrict travel between Manitoba and Quebec, and the police will set up checkpoints at the provincial borders.

The new measures come amid a sluggish vaccine campaign in Canada and the latest virus wave there, driven largely in Ontario by the highly contagious B.1.1.7 variant first detected in Britain. The increasing case numbers have strained the capacity of intensive care units in many parts of the country.

Canada has inched ahead of the United States in new daily coronavirus cases per capita, and officials warned that worse is to come. By Friday, hospitalizations were up by 22 percent; I.C.U. admissions rose by 34 percent; and each day, 41 people died from Covid-19, a 38 percent increase from the previous week.

a variety of other measures.

The latest measures have been met with criticism, including from public health experts, the mayor of Toronto and several police departments, including the Toronto Police Service, which said on Twitter that it would “not be doing random stops of people or cars.” There were also concerns that asking the police to impose such measures could result in racial profiling.

“I know you are all sick and tired of Covid-19,” Prime Minister Justin Trudeau said on Friday as he urged Canadians to follow their provinces’ rules. “We all just want to be done with this.”

Emergency rooms, particularly in Ontario, are reaching their breaking points, as are intensive care units. In a bid to ease the strain, children’s hospitals in both Ottawa and Toronto opened their I.C.U. beds to adults.

Many factors are behind the increasing numbers. Among them is the arrival of more infectious variants of the virus. An outbreak of P.1, the variant first found in Brazil, spread throughout British Columbia and then into Alberta. Manitoba discovered its first case of the variant this week.

Moderna is delaying deliveries of its vaccine shipment to Canada and other countries, and the Johnson & Johnson vaccine, which has yet to arrive in Canada, has come under safety scrutiny.

Pfizer will sell Canada an additional eight million doses of the vaccine it has developed with BioNTech, half of which will arrive next month, and all of which will arrive by the end of July.

Many Canadians are frustrated as they see higher vaccination rates in Britain and the United States.

Canada’s vaccination strategy has been to delay second doses to allow more residents to gain the protection from at least one shot. About 2 percent of Canadians are fully vaccinated compared with 25 percent of Americans, and 19 percent have received at least one dose compared with 39 percent in the United States. Yet the scheduled increases in vaccine shipments — the Moderna slip up aside — should help Canada catch up over the next few weeks.

Farah Mohamed contributed reporting.

View Source

A Week of Discouraging Coronavirus Pandemic Developments in Canada

I was feeling vaguely guilty this week when heading out to a sports complex in suburban Ottawa for my vaccination. As I write this, only 19 percent of Canadians have shared my experience and just before my vaccine day arrived, tens of thousands of vaccination appointments in Manitoba and Ontario were canceled.

pulled slightly ahead of the United States in average daily new cases per capita. Moderna cut deliveries of its vaccine to Canada and other countries while the Johnson & Johnson vaccine, which has yet to arrive in Canada, has come under safety scrutiny.

paused the use of Johnson & Johnson’s one-dose vaccine over concerns that it might be linked to a rare but serious blood-clotting disorder. Canada is expecting its first shipment of that vaccine — 300,000 doses — on April 27.

My colleagues Denise Grady and Carl Zimmer examined the blood-clotting risk potentially posed by that vaccine as well as the AstraZeneca vaccine. Their bottom line: If there is a risk, it’s low.

[Read: J & J Vaccine and Blood Clots: The Risks, if Any, Are Very Low]

But perhaps offsetting all that is Mr. Trudeau’s announcement that Pfizer will sell Canada an additional eight million doses of the vaccine it has developed with BioNTech, half of which will arrive next month, and all of which will arrive by the end of July. The company will also be sending earlier purchases sooner. All that may mean that all Canadian adults will have received at least one shot by July, the prime minister said.

an immediate pause in the use of Johnson & Johnson’s single-dose Covid-19 vaccine after six recipients in the United States developed a rare disorder involving blood clots within one to three weeks of vaccination.

  • All 50 states, Washington, D.C. and Puerto Rico temporarily halted or recommended providers pause the use of the vaccine. The U.S. military, federally run vaccination sites and a host of private companies, including CVS, Walgreens, Rite Aid, Walmart and Publix, also paused the injections.
  • Fewer than one in a million Johnson & Johnson vaccinations are now under investigation. If there is indeed a risk of blood clots from the vaccine — which has yet to be determined — that risk is extremely low. The risk of getting Covid-19 in the United States is far higher.
  • The pause could complicate the nation’s vaccination efforts at a time when many states are confronting a surge in new cases and seeking to address vaccine hesitancy.
  • Johnson & Johnson has also decided to delay the rollout of its vaccine in Europe amid concerns over rare blood clots, dealing another blow to Europe’s inoculation push. South Africa, devastated by a more contagious virus variant that emerged there, suspended use of the vaccine as well. Australia announced it would not purchase any doses.
  • As I pulled into a parking lot, a man in an orange vest told me to stay in the car until my appointment time was announced over a very loud loudspeaker to avoid people congregating. After passing through two screenings by people who remained welcoming, despite having to endlessly ask the same questions, and a registration check in, I received a shot four minutes after my scheduled appointment time. It was injected by someone more than qualified for the task: an orthopedic surgeon.

    Canada’s decision to get at least one shot into as many people as possible means that I’m not scheduled for a second dose until August.

    As many Canadians look at vaccination rates in Britain and the United States, their frustration has been growing. Right now, just 2 percent of Canadians are fully vaccinated compared with 24 percent of Americans. But the scheduled increases in vaccine shipments — the Moderna slip up aside — should help Canada catch up slightly over the next few weeks.

    If so, it will also be a relief to the medical world. After he released the projections compiled by Ontario’s table of science experts on Friday, which indicated cases could hit 30,000 a day if nothing is done, Adalsteinn Brown, the dean of the Dalla Lana School of Public Health at the University of Toronto, said, “More vaccination, more vaccination, more vaccination.”


    built 100 tiny shelters for homeless people to get though the winter. He now has an even bigger plan.

  • Geneva Abdul, a Times colleague now based in London and former member of Canada’s national soccer team, wrote about the confidence that playing the sport gave her.

  • An exhaustive review found that anti-gay bias by Toronto police helped allow a serial killer to prey on the city’s gay community.

  • William Amos, a Liberal member of Parliament from Quebec, stripped down after a jog while not realizing that his computer’s camera was on and broadcasting to his fellow lawmakers in a virtual meeting. Now some people are asking who leaked the photo of Mr. Amos standing nude to the public.


  • A native of Windsor, Ontario, Ian Austen was educated in Toronto, lives in Ottawa and has reported about Canada for The New York Times for the past 16 years. Follow him on Twitter at @ianrausten.


    How are we doing?
    We’re eager to have your thoughts about this newsletter and events in Canada in general. Please send them to nytcanada@nytimes.com.

    Like this email?
    Forward it to your friends, and let them know they can sign up here.

    View Source

    Retail Sales Jump and Jobless Claims Drop in New Signs of Recovery: Live Updates

    filed first-time claims for state unemployment benefits last week, the Labor Department said Thursday, a decrease of 153,000 from the previous week.

    In addition, 132,000 filed for Pandemic Unemployment Assistance, a federal program that covers freelancers, part-timers and others who do not routinely qualify for state benefits. That was a decline of 20,000 from the previous week.

    Neither figure is seasonally adjusted.

    In another sign of the recovery underway, retail sales surged in March, the Commerce Department said on Thursday, as Americans spent their latest round of government stimulus checks and the continued roll out of coronavirus vaccines lured more people back into stores.

    The 9.8 percent increase last month was a strong comeback from the nearly 3 percent drop in February.

    With the pandemic’s end seemingly in sight, the economy is poised for a robust comeback. But weekly applications for unemployment claims have remained stubbornly high for months, frustrating the recovery even as businesses reopen and vaccination rates increase.

    “The job market conditions for job seekers have really improved extremely quickly between January and now,” said Julia Pollak, a labor economist at the job site ZipRecruiter. “But there are still huge barriers to returning to work.”

    Jobless claims for the next few months could remain much higher than they were before the pandemic as the labor market adjusts to a new normal.

    Concerns about workplace safety persist, especially for workers who are not yet vaccinated. Many children are still attending schools remotely, complicating the full-time work prospects for their caregivers.

    But there is hope on the horizon as those barriers begin to fall. President Biden moved up the deadline for states to make all adults eligible for vaccination to April 19, and every state has complied. Students who have been learning remotely will begin to return to the classroom in earnest.

    “This was the deepest, swiftest recession ever, but it’s also turning into the fastest recovery,” Ms. Pollak said. “And I don’t think we should lose sight of that just because some of the measures are a little stubborn.”

    A store in Lower Manhattan. Retail sales rebounded in March, highlighting the importance of stimulus payments to consumer spending.
    Credit…Gabby Jones for The New York Times

    Retail sales surged in March, the Commerce Department said on Thursday, as Americans spent their latest round of government stimulus checks and the continued roll out of coronavirus vaccines lured more people back into stores.

    The 9.8 percent increase last month was a strong comeback from the nearly 3 percent drop in February, when previous stimulus money had dissipated and a series of winter storms made travel difficult across much of the United States.

    The rebound in March sales shows how, a year after the nation’s economy locked down to prevent the spread of the virus, consumer spending remains highly dependent on government support. It also reflects that many areas of consumption frozen by the pandemic have bounced back. Sales of clothing and accessories rose 18 percent, while restaurants and bars saw a 13 percent increase.

    President Biden’s $1.9 trillion American Rescue Plan, which was signed into law last month, provides direct payments of $1,400 to lower-income Americans. Many of these checks began arriving in households toward the end of last month, when economists saw signs that spending was ramping up again, such as increased hotel occupancy and travel through airports.

    Economists at Morgan Stanley had predicted that core retail sales would jump 6.5 percent in March, driven by the stimulus checks that started arriving in people’s bank accounts around March 17. The investment bank said 30 percent of consumers tend to spend their checks within the first 10 days, suggesting that many other consumers have yet to spend their checks, which could strengthen April sales.

    More broadly, American consumers are also feeling increasingly optimistic as more people become vaccinated and venture out more frequently. One measure of consumer confidence, tabulated by the Conference Board, said confidence increased about 20 points in March from February, fueled by increased income and stronger business and employment expectations.

    The Thomson Reuters offices in Times Square. The company’s media organization will begin charging for access to its website.
    Credit…Andrew Kelly/Reuters

    Reuters will begin charging for access to its website as it tries to capture a slice of the digital subscription business.

    The company, one of the largest news organizations in the world, announced the new paywall on Thursday, as well as a redesigned website aimed at a “professional” audience wanting business, financial and general news.

    After registration and a free preview period, a subscription to Reuters.com will cost $34.99 a month, the same as Bloomberg’s digital subscription. The Wall Street Journal’s digital subscription costs $38.99 a month, while The New York Times costs $18.42 monthly.

    Reuters.com attracts 41 million unique visitors a month. Months of audience research showed that those readers were divided in two separate groups: those wanting breaking news and professionals looking for context and analysis about how news affected their industry, Josh London, chief marketing officer at Reuters, said in an interview.

    Reuters will roll out new sections on its website for subscribers in coming weeks that include coverage of legal news, sustainable business, energy, health care and the auto industry. It also plans to introduce industry-specific newsletters.

    Mr. London described the new website as “the largest digital transformation at Reuters in a decade.” He declined to provide specifics on digital subscription goals but said that it represented “a major opportunity for us.”

    Arlyn Gajilan, the digital news director at Reuters, said she expected to expand the digital team working on the revamped website.

    On Monday, Reuters announced that Alessandra Galloni, a global managing editor, would become its next editor in chief. Ms. Galloni, who will be the first woman to helm the news agency in its history, starts her new role on Monday. She takes over from Stephen J. Adler, who retired after running Reuters for a decade.

    Ms. Gajilan said that Ms. Galloni had been closely involved in the new direction of Reuters.com.

    “She’s a very strong advocate for all things digital at Reuters,” Ms. Gajilan said.

    Coinbase’s market debut was displayed on the Nasdaq tower in Times Square on Wednesday.
    Credit…Gabby Jones for The New York Times

    U.S. stocks are set to rise when trading begins on Thursday as more companies report first-quarter earnings and retail sales data is expected to show a big increase in spending in March.

    The S&P 500 was expected to open 0.5 percent higher, futures indicated.

    After a bumper market debut, Coinbase shares rose 11 percent in premarket trading. On Wednesday, the cryptocurrency exchange ended its first day of trading at $328.28 a share, valuing the company at nearly $86 billion — more than 10 times its last valuation as a private company.

    Shares in Bank of America rose 2.5 percent in premarket trading after the company reported better-than-expected revenue from sales and trading. The bank joins its peers in reporting a jump in earnings. On Wednesday, executives at Goldman Sachs, JPMorgan Chase and Wells Fargo all delivered upbeat economic forecasts.

    Retail sales rose 5.8 percent in March, according to economists surveyed by Bloomberg, rebounding from a 3 percent drop the previous month.

    Dan Rozycki, president of the Transtec Group in Texas, is looking at alternatives for his semiconductor supplies.
    Credit…Ilana Panich-Linsman for The New York Times

    Shortages of semiconductors, fueled by pandemic interruptions and production issues at multibillion-dollar chip factories, have sent shock waves through the economy. Questions about chips are reverberating among both businesses and policymakers trying to navigate the world’s dependence on the small components.

    Most attention has focused on temporary closings of big U.S. car plants. But the chips are in everything from cash registers and kitchen appliances, and the problem is affecting many other sectors, particularly the server systems and PCs used to deliver and consume internet services that became crucial during the pandemic, Don Clark reports for The New York Times.

    “Every aspect of human existence is going online, and every aspect of that is running on semiconductors,” said Pat Gelsinger, the new chief executive of the chip maker Intel who attended the meeting with the president on Monday. “People are begging us for more.”

    The chip shortage potentially affects just about any company adding communications or computing features to products. Many examples were described in 90 comments filed by companies and trade groups to a supply chain review by President Biden, including a laundry list of needs from industry giants like Amazon and Boeing.

    Dan Rozycki is the president of a small engineering firm, that sells small sensors used to monitor construction sites to ensure concrete is hardening properly. His firm is for now among the lucky chip users. It planned ahead and has enough chips to keep making the roughly 50,000 sensors it supplies each year to construction sites. But his distributor has warned him it might not be able to deliver more of them until late 2022, he said.

    “Is that going to halt those projects?” Mr. Rozycki asked. He is scouring the market for other distributors that might have the two needed chips in stock. Other possibilities include redesigning the sensors to use different chips.

    Instagram is developing a service for children as a way to keep those under 13 off its main platform.
    Credit…Jenny Kane/Associated Press

    An international coalition of 35 children’s and consumer groups called on Instagram on Thursday to scrap its plans to develop a version of the popular photo-sharing app for users under age 13.

    Instagram’s push for a separate children’s app comes after years of complaints from legislators and parents that the platform has been slow to identify underage users and protect them from sexual predators and bullying.

    But in a letter to Mark Zuckerberg, the chief executive of Facebook — the company that owns the photo-sharing service — the nonprofit groups warned that a children’s version of Instagram would not mitigate such problems. While 10- to 12-year-olds with Instagram accounts would be unlikely to switch to a “babyish version” of the app, the groups said, it could hook even younger users on endless routines of photo-scrolling and body-image shame.

    “While collecting valuable family data and cultivating a new generation of Instagram users may be good for Facebook’s bottom line,” the groups, led by the Campaign for a Commercial-Free Childhood in Boston, said in the letter to Mr. Zuckerberg, “it will likely increase the use of Instagram by young children who are particularly vulnerable to the platform’s manipulative and exploitative features.”

    The coalition of nonprofit groups also includes the Africa Digital Rights’ Hub in Ghana; the Australian Council on Children and the Media; the Center for Digital Democracy in Washington; Common Sense Media in San Francisco; the Consumer Federation of America; and the 5Rights Foundation in Britain.

    Stephanie Otway, a Facebook spokeswoman, said that Instagram was in the early stages of developing a service for children as part of an effort to keep those under 13 off its main platform. Although Instagram requires users to be at least 13, many younger children have lied about their age to set up accounts.

    Ms. Otway said that company would not show ads in any Instagram product developed for children younger than 13, and that it planned to consult with experts on children’s health and safety on the project. Instagram is also working on new age-verification methods to catch younger users trying to lie about their age, she said.

    “The reality is that kids are online,” Ms. Otway said. “They want to connect with their family and friends, have fun and learn, and we want to help them do that in a way that is safe and age-appropriate.”

    View Source

    Reuters Puts Its Website Behind a Paywall

    Reuters will begin charging for access to its website as it tries to capture a slice of the digital subscription business.

    The company, one of the largest news organizations in the world, announced the new paywall on Thursday, as well as a redesigned website aimed at a “professional” audience wanting business, financial and general news.

    After registration and a free preview period, a subscription to Reuters.com will cost $34.99 a month, the same as Bloomberg’s digital subscription. The Wall Street Journal’s digital subscription costs $38.99 a month, while The New York Times costs $18.42 monthly.

    Reuters.com attracts 41 million unique visitors a month. Months of audience research showed that those readers were divided in two separate groups: those wanting breaking news and professionals looking for context and analysis about how news affected their industry, Josh London, chief marketing officer at Reuters, said in an interview.

    announced that Alessandra Galloni, a global managing editor, would become its next editor in chief. Ms. Galloni, who will be the first woman to helm the news agency in its history, starts her new role on Monday. She takes over from Stephen J. Adler, who retired after running Reuters for a decade.

    Ms. Gajilan said that Ms. Galloni had been closely involved in the new direction of Reuters.com.

    “She’s a very strong advocate for all things digital at Reuters,” Ms. Gajilan said.

    View Source

    A Ramadan Closer to Normal for 2021

    CAIRO — Compared with Ramadan 2020, when mosques around the world were closed for prayer during the holiest month of the year for Muslims, and curfews prevented friends and family from gathering to break the fast, the religious holiday this year offered the promise of something much closer to normal.

    “Last year, I felt depressed and I didn’t know how long the pandemic would last,” said Riyad Deis, a co-owner of a spice and dried-fruit shop in Jerusalem’s Old City. On Tuesday, the first day of the Muslim fasting month, its narrow alleys were alive with shoppers browsing Ramadan sweets and worshipers heading to the Al-Aqsa Mosque.

    Mr. Deis, 51, who was selling whole pieces of turmeric and Medjool dates to a customer, recalled how empty and subdued the Old City had felt last year as virus cases surged and the authorities closed Al-Aqsa to the public. “Now, I’m relaxed, I have enough money to provide for my family and people are purchasing goods from my shop,” he said. “It’s a totally different reality.”

    rising coronavirus infections across many countries.

    In Kenya, the authorities have introduced longer curfews, closed bars and schools, restricted gatherings at spaces of worship, and limited travel in and out of five counties including Nairobi, the capital.

    For Nairobi residents like Ahmed Asmali, this means a prolonged inability to break the fast with loved ones or attend prayers with larger congregations.

    “It’s the second year now that we are in a lockdown,” said Mr. Asmali, a 41-year-old public relations worker. The experience, he said “feels weird. Feels out of place.”

    Lebanon Crisis Observatory, a project by the American University in Beirut.

    The pandemic still shadows much of the festivities. Shop owners in Jerusalem’s Old City said they were worried that Israel would not allow large numbers of Palestinians from the West Bank, where few have been vaccinated, to visit the Old City this Ramadan, depriving the area of their holiday spending.

    Prepandemic, Israel usually allowed tens of thousands of Palestinians from the West Bank to visit Jerusalem on Fridays during the fasting month. The arm of the Israeli government that liaises with the Palestinian Authority said on Tuesday that Israel would allow 10,000 vaccinated Palestinians from the West Bank to pray at the Aqsa on Friday. It also said authorities would permit 5,000 vaccinated Palestinians from the West Bank to make family visits in Israel between Sunday and Thursday next week.

    Omar Kiswani, the director of the Aqsa Mosque, said he was overjoyed that the compound was open to worshipers — an estimated 11,000 attended the taraweeh prayers at the compound Monday evening — but he emphasized that people would still need to be careful. He said masks and two meters’ distance between worshipers are required at the mosque, and the indoor and outdoor spaces will be sterilized daily.

    “These are times of great happiness,” Mr. Kiswani said. “We hope the blessed Aqsa Mosque will return to its prepandemic glory. But these are also times of caution, because the virus is still out there.”

    Vivian Yee reported from Cairo, and Adam Rasgon from Jerusalem. Asmaa al-Omar contributed reporting form Istanbul and Abdi Latif Dahir from Nairobi.

    View Source

    Covid-19 Live Updates: U.S. Calls for Pause on Johnson & Johnson Vaccine, Complicating Rollout

    Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination.

    All six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition.

    Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.

    “We are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, and Dr. Anne Schuchat, principal deputy director of the C.D.C., said in a joint statement. “Right now, these adverse events appear to be extremely rare.”

    On a media call later on Tuesday morning, Dr. Marks said that “on an individual basis, a provider and patient can make a determination whether or not to receive the vaccine” manufactured by Johnson & Johnson.

    While the move was framed as a recommendation to health practitioners in the states, the federal government is expected to pause administration of the vaccine at all federally run vaccination sites. Federal officials expect that state health officials will take that as a strong signal to do the same. Within two hours of the announcement, Gov. Mike DeWine of Ohio, a Republican, advised all health providers in his state to temporarily stop giving Johnson & Johnson shots. In New York, the health commissioner, Dr. Howard Zucker, said the state would halt the use of the vaccine statewide while federal officials evaluate the safety risks. Appointments for Johnson & Johnson’s shot on Tuesday at state mass sites would be honored with Pfizer doses, Dr. Zucker said.

    The authorities in New Jersey, Connecticut, Massachusetts, Maryland, Nebraska, Georgia, Indiana, Texas and Virginia also said that they would follow the call from federal health agencies.

    Scientists with the F.D.A. and C.D.C. will jointly examine possible links between the vaccine and the disorder and determine whether the F.D.A. should continue to authorize use of the vaccine for all adults or limit the authorization.

    In the media call, federal health officials tried to reassure recipients of Johnson & Johnson’s vaccine while at the same time describing symptoms that they should watch out if they received a shot within the past month.

    Dr. Schuchat said that the risk of dangerous blood clots is “very low” for people who received the vaccine more than a month ago.

    “For people who recently got the vaccine within the last couple of weeks, they should be aware, to look for any symptoms. If you receive the vaccine and develop severe headaches, abdominal pain, leg pain or shortness of breath, you should contact your health care provider and seek medical treatment,” she said. She emphasized that an emergency meeting of the C.D.C.’s outside advisory committee, which has been scheduled for Wednesday, to discuss how to handle the vaccine in the future is made up of independent experts.

    Dr. Janet Woodcock, acting commissioner of the Food and Drug Administration, said she expects the pause in distributing and administrating the vaccine will last for “a matter of days” while officials investigate the cases. Officials also stressed that no serious safety problems have emerged with either of the other two federally authorized vaccines, developed by Pfizer-BioNTech and Moderna.

    The move could substantially complicate the nation’s vaccination efforts at a time when many states are confronting a surge in new cases and seeking to address vaccine hesitancy. Regulators in Europe and elsewhere are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca and Oxford University researchers. That concern has driven up some resistance to all vaccines, even though the AstraZeneca version has not been authorized for emergency use in the United States.

    The vast majority of the nation’s vaccine supply comes from two other manufacturers, Pfizer-BioNTech and Moderna, which together deliver more than 23 million doses a week of their two-shot vaccines. There have been no significant safety concerns about either of those vaccines.

    But while shipments of the Johnson & Johnson vaccine have been much more limited, the Biden administration had still been counting on using hundreds of thousands of doses every week. In addition to requiring only a single dose, the vaccine is easier to ship and store than the other two, which must be stored at extremely low temperatures.

    Jeffrey D. Zients, the White House Covid-19 response coordinator, said Tuesday the pause “will not have a significant impact” the Biden administration’s plans to deliver enough vaccine to be able to inoculate all 260 million adults in the United States by the end of May. With the Johnson & Johnson setback, federal officials expect there will only be enough to cover fewer than 230 million adults. But a certain percentage of the population is expected to refuse shots, so the supply may cover all the demand.

    Mr. Zients said the administration will still “reach every adult who wants to be vaccinated” by the May 31 target.

    Federal officials are concerned that doctors may not be trained to look for the rare disorder if recipients of the vaccine develop symptoms of it. The federal health agencies said Tuesday morning that “treatment of this specific type of blood clot is different from the treatment that might typically be administered” for blood clots.

    “Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given,” the statement said.

    In a news release, Johnson & Johnson said: “We are aware that thromboembolic events including those with thrombocytopenia have been reported with Covid-19 vaccines. At present, no clear causal relationship has been established between these rare events and the Janssen Covid-19 vaccine.” Janssen is the name of Johnson & Johnson’s division that developed the vaccine.

    In the United States alone, 300,000 to 600,000 people a year develop blood clots, according to C.D.C. data. But the particular blood clotting disorder that the vaccine recipients developed, known as cerebral venous sinus thrombosis, is extremely rare.

    All of the women developed the condition within about two weeks of vaccination, and government experts are concerned that an immune system response triggered by the vaccine was the cause. Federal officials said there was broad agreement about the need to pause use of the vaccine while the cases are investigated.

    The decision is a fresh blow to Johnson & Johnson. Late last month, the company discovered that workers at a Baltimore plant run by its subcontractor had accidentally contaminated a batch of vaccine, forcing the firm to throw out the equivalent of 13 million to 15 million doses. That plant was supposed to take over supply of the vaccine to the United States from Johnson & Johnson’s Dutch plants, which were certified by federal regulators earlier this year.

    The Baltimore plant’s certification by the F.D.A. has now been delayed while inspectors investigate quality control issues, sharply reducing the supply of Johnson & Johnson vaccine. The sudden drop in available doses led to widespread complaints from governors and state health officials who had been expecting much bigger shipments of Johnson & Johnson’s vaccine this week than they got.

    A Kent State University student getting his Johnson & Johnson vaccination in Kent, Ohio, last week.
    Credit…Phil Long/Associated Press

    The authorities in Ohio, New York, New Jersey, Connecticut, Massachusetts, Maryland, Nebraska, Georgia, Indiana, Texas and Virginia said on Tuesday that they would follow the call from federal health agencies to pause the administration of Johnson & Johnson’s vaccine after six women in the United States developed a rare disorder involving blood clots within about two weeks of vaccination.

    CVS, the nation’s largest retail pharmacy chain, also said that it would immediately stop its use of Johnson & Johnson vaccinations and was emailing customers whose appointments would be canceled. A spokesman said that CVS would reschedule appointments “as soon as possible.”

    Gov. Mike DeWine of Ohio and the state’s chief health official said they were advising all state vaccine providers to temporarily halt use of the single-dose vaccine. New York’s health commissioner, Dr. Howard Zucker, said the state would stop using the Johnson & Johnson vaccine, while the Food and Drug Administration and the Centers for Disease Control and Prevention evaluate the safety risks.

    Connecticut health officials said they told vaccine providers to delay planned appointments and give an alternative option if they had the supply.

    The C.D.C.’s outside advisory committee has scheduled an emergency meeting for Wednesday.

    Jeff Zients, the White House Covid coordinator, said on Tuesday that the pause will not have a significant impact on the country’s vaccination campaign, which has accelerated in recent weeks as a rise in new virus cases threatens a fourth possible surge. Many states have already opened vaccination eligibility to all adults and others plan to by next week.

    “Over the last few weeks, we have made available more than 25 million doses of Pfizer and Moderna each week, and in fact this week we will make available 28 million doses of these vaccines. This is more than enough supply to continue the current pace of vaccinations of 3 million shots per day,” Mr. Zients said in a statement.

    Even though the reaction to the Johnson & Johnson shot is rare, any questions about the safety of the shots could bolster vaccine hesitancy.

    Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention. The six women who developed blood clots were between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition.

    “Right now, these adverse events appear to be extremely rare,” Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, and Dr. Anne Schuchat, principal deputy director of the C.D.C., said in a joint statement on Tuesday. “People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.”

    Like many states, New York had already prepared for a significant drop in its supply of the Johnson & Johnson vaccine after federal officials said that supplies would be limited because of a production issue at a Baltimore manufacturing plant. On Friday, Gov. Andrew M. Cuomo said that New York expected to receive 34,900 Johnson & Johnson shots, a decrease of 88 percent from the previous week.

    Dr. Zucker, New York’s health commissioner, said that the state would honor appointments made at state-run mass vaccination sites for the Johnson & Johnson vaccine by giving people the Pfizer-BioNTech vaccine instead. That vaccine requires two doses, and it was not immediately clear how the state would handle the additional strain on its supply.

    Mayor Bill de Blasio of New York City said that the city would work to reschedule appointments at city-run vaccine sites, giving those people the Pfizer or Moderna vaccines instead.

    “Every site has been told this morning to stop giving the J&J shots,” he said at a news conference.

    Mr. Cuomo received the Johnson & Johnson vaccine at a public appearance last month in Harlem, which he framed as an effort to boost confidence in that vaccine’s efficacy rate and to address vaccine hesitancy.

    Regulators in Europe and elsewhere are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca and Oxford University researchers. That vaccine has not been authorized for emergency use in the United States.

    Students line up for vaccines at Oakland University on Friday in Rochester, Mich. Coronavirus cases in the state have continued to rise in recent weeks.
    Credit…Emily Elconin for The New York Times

    The virus is again surging in parts of the United States, but it’s a picture with dividing lines: ominous figures in the Northeast and Upper Midwest, but largely not in the South.

    Experts are unsure what explains the split, which doesn’t correspond to vaccination levels. Some point to warmer weather in the Sun Belt, while others suspect that decreased testing is muddying the virus’s true footprint.

    The contours of where the virus is resurgent can be drawn around one figure: states that are averaging about 15 new cases a day for every 100,000 people. The 23 states — including Alabama, Mississippi and Arkansas — that have averaged that or fewer over the past week seem to be keeping cases relatively low, according to a New York Times database. Nationally, the country is averaging 21 new cases per 100,000 people.

    In the 27 states above that line, though, things have been trending for the worse. Michigan has the highest surge of all, reporting the most drastic increase in cases and hospitalizations in recent weeks. Illinois, Minnesota and others have also reported worrisome increases.

    Nationally, reported cases in the United States are growing again after a steep fall from the post-holiday peak in January. In the past two weeks, new confirmed cases have jumped about 11 percent, even though vaccinations picked up considerably, with an average of 3.2 million doses given daily.

    Some Southern states, like Alabama and Mississippi, are lagging in vaccinations. Only about 28 percent of people in each state have received at least one shot, according to a New York Times vaccine tracker. Still, case counts continue to drop in both states.

    Health experts say cases are rising in the Northeast and Upper Midwest for several reasons, including pandemic fatigue, the reopening of schools and the resumption of youth sports.

    Hospitalizations tend to follow the trend line in cases by a few weeks, and have been rising in some states, most notably in Michigan.

    Officials are also concerned about the spread of more contagious virus variants, especially B.1.1.7, first identified in Britain. The variant is now the leading source of new coronavirus infections in the United States, the director of the Centers for Disease Control and Prevention said last week.

    Just why those factors might affect some states more than others is hard to pinpoint, experts say.

    Dr. David Rubin, the director of PolicyLab at the Children’s Hospital of Philadelphia, said warmer weather in Southern states and California was probably playing a role, because it allows people to gather outdoors, with less risk of transmission.

    New case reports have fallen by about 11 percent in Georgia over the past two weeks. And in Alabama, new cases are down roughly 29 percent, with a 17 percent decline in hospitalizations.

    Some experts say, though, that reduced testing in some states could be obscuring the true picture. Testing in Alabama, for instance, has started to dip, but the share of tests that come back positive has remained high, at 11.1 percent, compared with a nationwide average of 5.1 percent, according to data compiled by Johns Hopkins University.

    “People who are symptomatic and go to their provider are going to get a test,” said Dr. Michael Saag, the associate dean for global health at the University of Alabama at Birmingham, but “the desire for people to go get tested just because they want to know what their status is has dropped off dramatically.”

    Still, Dr. Saag said, there is probably not a hidden spike in cases in Alabama right now, since hospitalizations in the state remain low.

    The first dawn prayers of Ramadan around the Kaaba at the Grand Mosque in Mecca, Saudi Arabia, on Tuesday.
    Credit…Amr Nabil/Associated Press

    Millions of Muslims on Tuesday began celebrating a second Ramadan in the middle of the pandemic, although in many countries the first day of the holy month offered the promise of a Ramadan with fewer restrictions than last year.

    Mosques across the Middle East and other parts of the world were closed for prayer last year, and lockdowns prevented festive gatherings with friends and family. In Jerusalem, for instance, the Old City was largely empty and the Aqsa Mosque compound was closed to the public, as coronavirus cases were surging.

    But a large degree of normalcy was back on Tuesday: The Old City’s narrow alleys were crowded, sweet shops were preparing Ramadan desserts, clothing stores were open and the Aqsa compound was welcoming worshipers.

    “Last year, I felt depressed and I didn’t know how long the pandemic would last,” said Riyad Deis, a co-owner of a spice and dried fruit shop in the Old City, while selling whole pieces of turmeric and Medjool dates to a customer. “Now, I’m relaxed, I have enough money to provide for my family and people are purchasing goods from my shop — it’s a totally different reality.”

    The enthusiasm of some didn’t mean the Ramadan would go as normal. Across several countries in the Middle East, the authorities imposed limitations on customs and festivities, requiring that mosques enforce social distancing and telling worshipers to bring their own prayer rugs and to wear face masks.

    In Dubai, Saudi Arabia and Egypt, taraweeh, the optional extra prayers that worshipers can observe at night, were capped at half an hour. No one will also be allowed to spend the night in a mosque, as is common during the last 10 days of Ramadan.

    Mosques around the region were also prohibited from serving the fast-breaking meal of iftar or the predawn meal of suhoor. Though Muslims could still gather for those meals with friends and family, the authorities asked them to limit those gatherings this year.

    In Jerusalem, Omar Kiswani, the director of Al Aqsa Mosque, said he was overjoyed that the compound was open to worshipers, but still urged caution.

    “These are times of great happiness — we hope the blessed Aqsa Mosque will return to its pre-pandemic glory — but these are also times of caution because the virus is still out there,” Mr. Kiswani said.

    In Egypt, government officials and prominent television hosts linked to the authorities warned Egyptians of a third wave of infections as Ramadan approached, hinting that another curfew or other lockdown restrictions could be imposed if cases rose.

    “If you want the houses of God to remain open,” Nouh Elesawy, an official who oversees mosques at the Egyptian Ministry of Endowments, said earlier this month, “adhere to the precautionary procedures and regulations.”

    The Ramadan restrictions may hit the hardest in poor neighborhoods, where residents depend on iftar banquets usually sponsored by wealthy individuals or organizations. For those people, feasting and Ramadan gifts are likely to be rarer, with tourism still at a trickle and many small businesses still suffering from the economic effects of the pandemic.

    In Lebanon and Syria, the pandemic has worsened economic crisis that will likely squeeze people’s ability to enjoy the holy month, more than the governments’ limited restrictions aimed at curbing the spread of the coronavirus.

    In Syria, where experts say the official infection and death numbers for Covid-19 are far below the reality, the government has few restrictions in place. Worshipers will even be allowed to stand in line inside of mosques to pray together after breaking their fast, the Syrian Ministry of Religious Affairs said.

    In Lebanon, which emerged recently from a strict lockdown, shops and restaurants can operate regularly during the day but must offer only delivery service during a nighttime curfew from 9:30 p.m. to 5 a.m.

    Global Roundup

    Administering a coronavirus vaccine to a frontline worker in New Delhi, last week.
    Credit…Rebecca Conway for The New York Times

    India said on Tuesday that it would fast-track the approval of vaccines in use in other countries, a move aimed at rapidly increasing the country’s vaccine supply as it battles what is currently the world’s biggest coronavirus outbreak.

    The Indian government said that it would grant emergency authorization to any foreign-made vaccine that had been approved for use by regulators in the United States, the European Union, Britain or Japan, or by the World Health Organization. The move had been recommended by a panel of Indian scientists and eliminates a requirement for drug companies to conduct local clinical trials.

    “The decision will facilitate quicker access to such foreign vaccines” and encourage imports of materials that would boost India’s vaccine manufacturing capacity, the government said in a statement.

    Earlier on Tuesday, India’s top drug regulator granted emergency approval to Sputnik V, the Russian-made vaccine, adding a third vaccine to the country’s arsenal on the same day that health officials recorded 161,736 new coronavirus infections in 24 hours.

    It was the seventh straight day that India has added more than 100,000 cases, according to a New York Times database. Only the United States has seen a faster rise in infections during the pandemic.

    India has administered about 105 million domestically produced vaccine doses for a population of 1.3 billion, but it is widely believed that the country needs to scale up inoculations rapidly because other measures have failed to control the virus. Many states have reimposed partial lockdowns and weekend curfews. In the country’s financial hub, Mumbai, health officials are racing to erect field hospitals as facilities report shortages of oxygen, ventilators and coronavirus testing kits.

    And there is the risk of a superspreading event with the gathering of millions of Hindu pilgrims for the annual Kumbh Mela festival on the banks of the Ganges River, where the authorities say they are powerless to enforce social distancing.

    India’s outbreak is reverberating worldwide as its pharmaceutical industry — which was supposed to manufacture and export hundreds of millions of doses of the AstraZeneca vaccine — is keeping most supplies at home. The approval of the Sputnik vaccine, whose first doses are expected to be available for use in weeks, offers hope that India could speed up its inoculation drive.

    But it is unclear at this stage whether India will be able to procure significant quantities of other vaccines, including the Pfizer, Moderna and Johnson & Johnson shots in use in the United States. Major Western nations have accumulated much of the global supply of those vaccines and manufacturers are struggling to meet the surging demand.

    India will import millions of Sputnik doses from Russia and then begin manufacturing the vaccine domestically, officials said. More than 850 million doses will be made, with some intended for export, Kirill Dmitriev, chief executive of the Russian Direct Investment Fund, a sovereign wealth fund that has financed the vaccine’s development, said in an interview with India’s NDTV channel.

    “India is a vaccine-manufacturing hub and our strategic partner for production of Sputnik V,” Mr. Dmitriev said.

    India has more than 13.6 million confirmed coronavirus cases, the second most after the United States, and 171,058 deaths, the fourth highest toll.

    In other news around the world:

    Chancellor Angela Merkel, center, at a cabinet meeting in Berlin on Tuesday. Her government’s proposal on coronavirus restrictions would place half the country over the threshold for lockdown.
    Credit…Pool photo by Andreas Gora

    BERLIN — Chancellor Angela Merkel’s government moved a step closer on Tuesday to securing the right to force restrictions on areas where the coronavirus is spreading rapidly, overriding state leaders reluctant to take action.

    Ms. Merkel and her ministers approved a legislative proposal that would make it easier for the national government to enforce lockdowns and other limits on movement in regions where infection levels pass a set threshold. At current levels, it could lock down more than half of the country.

    Under Germany’s decentralized leadership structures, the 16 state leaders have been meeting regularly with the chancellor to agree on nationwide coronavirus response policies. But with different regions experiencing different rates of infection, some state leaders have been reluctant to enforce the agreed limitations, leading to confusion and frustration among many Germans.

    “I believe this amendment is as important as it is an urgent decision about how to proceed in the coronavirus pandemic,” the chancellor told reporters after meeting with her ministers.

    Parliament still has to debate and approve the proposal, which would take the form of an amendment to the Protection Against Infection Act, and that process is expected to begin this week.

    “We are in a situation where an emergency mechanism is necessary,” Ralph Brinkhaus, the leader of the Christian Democratic Union in Parliament, told reporters, before a meeting of his party lawmakers to discuss the amendment.

    Under the proposed amendment, the federal government could force stores and cultural institutions to close and enforce limits on the number of people allowed to meet up in any region where infections surpass 100 new cases per 100,000 residents over a period of seven days.

    More controversially, the law would also allow Ms. Merkel’s government to order that schools and day care centers close if the number of new infections reaches more than 200 per 100,000 inhabitants. Schools fall under the jurisdiction of the states, and local leaders are reluctant to relinquish that control.

    Germany has registered more than three million infections and more than 78,700 deaths from Covid-19 since the virus began moving through the country last spring. It recorded 10,810 new cases of infection on Tuesday, bringing the national rate of infection to more than 140 per 100,000.

    The number of patients in intensive care is expected to hit a record this month, as the country struggles to vaccinate enough people to get ahead of the spread of the highly contagious B.1.1.7 variant.

    Vaccinations at a mosque in London earlier this month. Britain’s program has reached over 32 million people, more than half the adult population.
    Credit…Andrew Testa for The New York Times

    Britain has now offered vaccinations to everyone in the country age 50 and older, the government announced late on Monday, and is extending its program to another age group, the latest sign that the national rollout is continuing at pace.

    On Tuesday, the authorities opened vaccinations to anyone 45 or older, yet the announcement came with a small hiccup: The website for the country’s National Health Service crashed for a short time after the younger cohort was invited to book appointments online.

    The new step in the country’s vaccine rollout comes as the authorities eased several restrictions in England on Monday after months of stringent lockdowns, with pubs and restaurants opened for drinks and dining outside, and nonessential shops once again opening their doors.

    Prime Minister Boris Johnson called the moment a “hugely significant milestone” and in a statement thanked those involved with the vaccine rollout. Mr. Johnson said the country was on track to offer all adults a vaccination by the end of July. More than 32 million people across Britain have received their first dose of one of the vaccines, according to government data.

    The government said it had also already offered vaccinations to every health or care worker, and to everyone with a high-risk medical condition.

    England has also began rolling out the Moderna vaccine, which will be offered as an alternative alongside the Pfizer BioNTech vaccine for those under 30, instead of AstraZeneca’s, which has been the mainstay of Britain’s program so far.

    There have been concerns about a possible link between the AstraZeneca vaccine and very rare blood clots, and last week British regulators said an alternative should be provided for younger people. Potential infection still poses much greater risks than any vaccine side effect for all those over 30, they said, and could do so for younger people if cases surged again.

    “The Moderna rollout marks another milestone in the vaccination program,” Stephen Powis, the medical director of the National Health Service, said in a statement. “We now have a third jab in our armory.”

    The vaccination program, he added, “is our hope at the end of a year like no other” as he encouraged people to book their appointments.

    But despite the hopeful vaccine news and the return to public life, the country is still battling new cases of the virus, and a cluster in two London neighborhoods of a worrisome variant first discovered in South Africa has prompted mass testing. Health workers have gone door to door to urge residents to get tested, even if they are not showing symptoms, as dozens of cases have emerged. Similar measures were carried out elsewhere in the city earlier this month.

    Studies have shown that the variant contains a mutation that diminishes the vaccines’ effectiveness against it. Dr. Susan Hopkins, the chief medical adviser for the country’s test and trace campaign, said the cluster of cases in parts of South London was “significant.”

    “It’s really important people in the local area play their part in stopping any further spread within the local community,” she said in a statement.

    Pacific Palace, a dim sum restaurant on a commercial strip in the Sunset Park section of Brooklyn, has seen revenue plunge.
    Credit…Victor J. Blue for The New York Times

    More than a year after the coronavirus first swept through New York, the streets of Sunset Park in southern Brooklyn reflect the pandemic’s deep and unhealed wounds intertwined with signs of a neighborhood trying to edge back to life.

    The sidewalks are filling with shoppers and vendors. More businesses are welcoming customers. But owners still struggle to pay rent and keep their enterprises afloat, while many workers laid off after the city locked down last year remain without jobs.

    And while the rate of vaccination in New York has increased significantly, the coronavirus still percolates through this densely packed neighborhood. The ZIP code that includes Sunset Park had the highest rate of positive cases in Brooklyn in early April, nearly double the citywide rate. Some residents have expressed skepticism about the vaccines, spooked by false information circulated over TikTok and other social media.

    Adding to the stress is a spate of hate crimes and violence against people of Asian descent in New York and around the country, fed in some cases by racist claims that Asian-Americans are responsible for spreading the virus.

    About a third of the residents in Sunset Park have received at least one dose of the vaccine, roughly the same level as the city overall, according to the city health data. But local leaders say they want to push that number much higher.

    Kuan Neng, 49, the Buddhist monk who founded Xi Fang Temple on Eighth Avenue, said that people had come to him in recent weeks to express concerns over vaccines.

    “Why do I need to do that?” is a common refrain, according to Mr. Kuan, followed by: “I’m healthy now. The hard times are over, more or less.”

    “Many people want to delay and see,” Mr. Kuan said, himself included.

    The owner of the Cinerama Dome in Hollywood and 15 other movie theaters said it would not reopen after the pandemic.
    Credit…Kate Warren for The New York Times

    ArcLight Cinemas, a beloved chain of movie theaters based in Los Angeles, including the Cinerama Dome in Hollywood, will permanently close all its locations, Pacific Theaters announced on Monday, after the pandemic decimated the cinema business.

    ArcLight’s locations in and around Hollywood have played host to many a movie premiere, in addition to being favorite spots for moviegoers seeking out blockbusters and prestige titles. They are operated by Pacific Theaters, which also manages a handful of theaters under the Pacific name, and are owned by Decurion.

    “After shutting our doors more than a year ago, today we must share the difficult and sad news that Pacific will not be reopening its ArcLight Cinemas and Pacific Theaters locations,” the company said in a statement.

    “This was not the outcome anyone wanted,” it added, “but despite a huge effort that exhausted all potential options, the company does not have a viable way forward.”

    Between the Pacific and ArcLight brands, the company owned 16 theaters and more than 300 screens.

    The movie theater business has been hit particularly hard by the pandemic. But in recent weeks, the majority of the country’s largest theater chains, including AMC and Regal Cinemas, have reopened in anticipation of the slate of Hollywood films that have been put back on the calendar, many after repeated delays because of pandemic restrictions. A touch of optimism is even in the air as a result of the Warner Bros. movie “Godzilla vs. Kong,” which has generated some $70 million in box office receipts since opening over Easter weekend.

    Still, the industry’s trade organization, the National Association of Theater Owners, has long warned that the punishing closures were most likely to affect smaller regional players like ArcLight and Pacific. In March, the Alamo Drafthouse Cinema chain, which operates about 40 locations across the country, announced that it had filed for Chapter 11 bankruptcy protection but would keep most of its locations operational while it restructured.

    That does not seem to be the case for Pacific Theaters, which, according to two people with knowledge of the matter, fired its entire staff on Monday.

    The reaction to ArcLight’s closing around Hollywood has been emotional, including an outpouring on Twitter.

    Firefighters at the site of COVID-19 hospital Matei Bals, after a fire broke out in one of its buildings in Bucharest, Romania, in January.
    Credit…Robert Ghement/EPA, via Shutterstock

    Three people infected with the coronavirus died at a hospital in Bucharest on Monday evening after the oxygen supply stopped functioning, according to the authorities, the latest incident involving oxygen failure, which in many countries has driven up the virus death toll.

    It was also another fatal setback for Romania’s ageing and overwhelmed health care system, which has suffered two fires in Covid-19 wards in recent months, killing at least 15 people.

    Ventilators shut down at a mobile intensive care unit set up at the Victor Babes hospital in Bucharest after oxygen pressure reached too high a level, the country’s health authorities said in a statement, depriving patients of a vital supply. In addition to the three patients who died, five others were evacuated and moved to other facilities in the city.

    Romania has recorded its highest rate of Covid-19 patients in intensive care units since the pandemic began, and on Sunday Prime Minister Florin Citu said that there were just six intensive care beds available across Romania, out of nearly 1,600.

    Intensive care units in Hungary and Poland have also been at risk of being overwhelmed, as much of Eastern Europe has struggled to cope with a third wave of infections across the continent. Some Hungarian hospitals have sought medical students and volunteers to assist in Covid-19 wards, giving training to those without previous medical experience.

    The mobile unit struck by the oxygen problem on Monday had only been in operation since Saturday, and it has epitomized long-running concerns over the country’s fragile health care system. In January, five patients died and a further 102 were evacuated from a different hospital in Bucharest after a fire broke out. In November, 10 patients hospitalized with the coronavirus died after a fire broke out in a hospital in the northeastern city of Piatra Neamt.

    Romania’s spending on health care is among the lowest in the European Union, with just over five percent of gross domestic product allocated toward it, compared with 10 percent on average among other countries of the bloc.

    More than 25,000 people who tested positive for the virus have died in Romania, and the authorities have closed schools and kindergartens throughout April as part of an extended Easter holiday.

    The authorities have so far administered more than 3.5 million vaccine doses, in a population of about 19 million.

    Alisa Stephens, a biostatistician at the University of Pennsylvania in Philadelphia, had to manage work and taking care of her children after the city went into lockdown last year.
    Credit…Hannah Yoon for The New York Times

    Studies have found that women in academia have published fewer papers, led fewer clinical trials and received less recognition for their expertise during the pandemic.

    Add to that the emotional upheaval of the pandemic, the protests over structural racism, worry about children’s mental health and education, and the lack of time to think or work, and an already unsustainable situation becomes unbearable.

    Michelle Cardel, an obesity researcher at the University of Florida, worries that this confluence of factors could push some women to leave the sciences.

    “My big fear is that we are going to have a secondary epidemic of loss, particularly of early career women in STEM,” she said.

    Female scientists were struggling even before the pandemic. It was not unusual for them to hear that women were not as smart as men, or that a woman who was successful must have received a handout along the way, said Daniela Witten, a biostatistician at the University of Washington in Seattle.

    Women in academia often have little recourse when confronted with discrimination. Their institutions sometimes lack the human resources structures common in the business world.

    Compounding the frustration are outdated notions about how to help women in science. But social media has allowed women to share some of those concerns and find allies to organize and call out injustice when they see it, said Jessica Hamerman, an immunologist at the Benaroya Research Institute in Seattle.

    In November, for example, a study on female scientists was published in the influential journal Nature Communications suggesting that having female mentors would hinder the career of young scientists and recommending that young women seek out male help.

    The response was intense and unforgiving: Nearly 7,600 scientists signed a petition calling on the journal to retract the paper — which it did on Dec. 21.

    The study arrived at a time when many female scientists were already worried about the pandemic’s effect on their careers, and already on edge and angry with a system that offered them little support.

    Alisa Stephens found working from home to be a series of wearying challenges. Dr. Stephens is a biostatistician at the University of Pennsylvania, and carving out the time and mental space for that work with two young children at home was impossible.

    Things eased once the family could safely bring in a nanny, but there was still little time for the deep thought Dr. Stephens had relied on each morning for her work.

    Over time, she has adjusted her expectations of herself. “Maybe I’m at 80 percent as opposed to 100 percent,” she said, “but I can get things done at 80 percent to some extent.”

    View Source

    Could the Pandemic Prompt an ‘Epidemic of Loss’ of Women in the Sciences?

    Like many women during the pandemic, Alisa Stephens found working from home to be a series of wearying challenges.

    Dr. Stephens is a biostatistician at the University of Pennsylvania, and the technical and detail-oriented nature of her work requires long uninterrupted stretches of thought. Finding the time and mental space for that work with two young children at home proved to be an impossibility.

    “That first month was really hard,” she recalled of the lockdown. Her infant daughter’s day care was closed, and her 5-year-old was at home instead of at school. With their nanny unable to come to the house, Dr. Stephens tended to her children all day and worked late into the evening. In the fall, when her daughter was set to begin kindergarten, the schools did not reopen.

    Things eased once the family could safely bring in a nanny, but there was still little time for the deep thought Dr. Stephens had relied on each morning for her work. Over time, she has adjusted her expectations of herself.

    studies have found that women have published fewer papers, led fewer clinical trials and received less recognition for their expertise during the pandemic.

    Add to that the emotional upheaval and stress of the pandemic, the protests over structural racism, worry about children’s mental health and education, and the lack of time to think or work, and an already unsustainable situation becomes unbearable.

    “The confluence of all of these factors creates this perfect storm. People are at their breaking point,” said Michelle Cardel, an obesity researcher at the University of Florida. “My big fear is that we are going to have a secondary epidemic of loss, particularly of early career women in STEM.”

    Female scientists were struggling even before the pandemic. It was not unusual for them to hear that women were not as smart as men, or that a woman who was successful must have received a handout along the way, said Daniela Witten, a biostatistician at the University of Washington in Seattle. Some things are changing, she said, but only with great effort, and at a glacial pace.

    steep for mothers. Even during maternity leave, they are expected to keep up with lab work, teaching requirements, publications and mentoring of graduate students. When they return to work, most do not have affordable child care.

    Women in academia often have little recourse when confronted with discrimination. Their institutions sometimes lack the human resources structures common in the business world.

    it will be far from enough.

    “It’s sort of like if you’re drowning, and the university tells you, ‘Don’t worry if it takes you an extra year to get back to shore,’” Dr. Witten said. “It’s like, ‘Hey, that’s not helpful. I need a flotation device.’”

    study on female scientists was published in the influential journal Nature Communications, suggesting that having female mentors would hinder the career of young scientists and recommending that the young women instead seek out men to help them.

    The response was intense and unforgiving.

    Hundreds of scientists, male and female, renounced the paper’s flawed methods and conclusions, saying it reinforced outdated stereotypes and neglected to take structural biases in academia into account.

    “The advice from the paper was basically similar to advice your grandmother may have given you 50 years ago: Get yourself a man who will take care of you, and all will be fine,” Dr. Cardel said.

    Nearly 7,600 scientists signed a petition calling on the journal to retract the paper — which it did on Dec. 21.

    The study arrived at a time when many female scientists were already worried about the pandemic’s effect on their careers, and already on edge and angry with a system that offered them little support.

    “It’s been an incredibly difficult time to be a woman in science,” said Leslie Vosshall, a neuroscientist at Rockefeller University in New York. “We’re already on the ground, we’re already on our knees — and then the paper just comes and kicks us to say: ‘We have the solution, let’s move the graduate students to a senior man.’”

    reconsidered their dude walls, Dr. Vosshall said. “There are some traditions that should not be perpetuated.”

    View Source

    ‘Tell Us if He’s Dead’: Abductions and Torture Rattle Uganda

    Mr. Kasato, the district councilor, said that plainclothes officers picked him up from a church meeting on Feb. 8, threw him, hooded, into a car and clobbered him.

    He said the men asked him for the evidence of election rigging he’d collected, and whether he had sent it to Mr. Wine’s party. He said, yes, he had.

    Mr. Kasato, a 47-year-old father of 11, said that while he was chained to the ceiling, his feet barely touching the ground, military officers whipped him with a wire and pulled at his skin with pliers.

    “It was a big shock,” he said. “I was praying deeply that I really survive that torture.”

    In late February, Mr. Kasato was charged with inciting violence during the November protests in which security forces killed dozens of people — accusations he denies. He has been released on bail, but said he was still in intense physical pain, and that his doctors advised he seek medical attention abroad.

    Analysts say that Mr. Museveni, 76, who has ruled Uganda since 1986, is trying to avoid history repeating itself. He himself was a charismatic young upstart who accused his predecessor, Mr. Obote, of rigging an election, and led an armed rebellion that after five years managed to take power.

    Mr. Wine, 39, whose real name is Robert Kyagulanyi, has become the face of this young movement, promising to shake up the country’s stifled politics. As his campaign gained ground last year, he was arrested and beaten and placed under de facto house arrest.

    “We are seeing a movement toward full totalitarianism in this country,” said Nicholas Opiyo, a leading human rights lawyer. He was abducted last December and released, charged with money laundering after his legal advocacy group received a grant from American Jewish World Service, a New York-based nonprofit.

    View Source

    Biden Details $1.52 Trillion Spending Proposal to Fund Discretionary Priorities

    WASHINGTON — President Biden outlined a vast expansion of federal spending on Friday, calling for a 16 percent increase in domestic programs as he tries to harness the government’s power to reverse what officials called a decade of underinvestment in the nation’s most pressing issues.

    The proposed $1.52 trillion in spending on discretionary programs would significantly bolster education, health research and fighting climate change. It comes on top of Mr. Biden’s $1.9 trillion stimulus package and a separate plan to spend $2.3 trillion on the nation’s infrastructure.

    Mr. Biden’s first spending proposal to Congress showcases his belief that expanding, not shrinking, the federal government is crucial to economic growth and prosperity. It would direct billions of dollars toward reducing inequities in housing and education, as well as making sure every government agency puts climate change at the front of its agenda.

    It does not include tax proposals, economic projections or so-called mandatory programs like Social Security, which will all be included in a formal budget document the White House will release this spring. And it does not reflect the spending called for in Mr. Biden’s infrastructure plan or other efforts he has yet to roll out, which are aimed at workers and families.

    Trump administration’s efforts to gut domestic programs.

    But Mr. Biden’s plan, while incomplete as a budget, could provide a blueprint for Democrats who narrowly control the House and Senate and are anxious to reassert their spending priorities after four years of a Republican White House.

    Democratic leaders in Congress hailed the plan on Friday and suggested they would incorporate it into government spending bills for the 2022 fiscal year. The plan “proposes long overdue and historic investments in jobs, worker training, schools, food security, infrastructure and housing,” said Senator Patrick J. Leahy of Vermont, the chairman of the Appropriations Committee.

    Shalanda D. Young, who is serving as Mr. Biden’s acting budget director, told congressional leaders that the discretionary spending process would be an “important opportunity to continue laying a stronger foundation for the future and reversing a legacy of chronic disinvestment in crucial priorities.”

    The administration is focusing on education spending in particular, seeing that as a way to help children escape poverty. Mr. Biden asked Congress to bolster funding to high-poverty schools by $20 billion, which it describes as the largest year-over-year increase to the Title I program since its inception under President Lyndon B. Johnson. The program provides funding for schools that have high numbers of students from low-income families, most often by providing remedial programs and support staff.

    The plan also seeks billions of dollars in increases to early-childhood education, to programs serving students with disabilities and to efforts to staff schools with nurses, counselors and mental health professionals — described as an attempt to help children recover from the pandemic, but also a longstanding priority for teachers’ unions.

    Mr. Biden heralded the education funding in remarks to reporters at the White House. “The data shows that it puts a child from a household that is a lower-income household in a position if they start school — not day care — but school at 3 and 4 years old, there’s overwhelming evidence that they will compete all the way through high school and beyond,” he said.

    There is no talk in the plans of tying federal dollars to accountability measures for teachers and schools, as they often were under President Barack Obama.

    his vision of having every cabinet chief, whether they are military leaders, diplomats, fiscal regulators or federal housing planners, charged with incorporating climate change into their missions.

    The proposal aims to embed climate programs into agencies that are not usually seen as at the forefront of tackling global warming, like the Agriculture and Labor Departments. That money would be in addition to clean energy spending in Mr. Biden’s proposed infrastructure legislation, which would pour about $500 billion on programs such as increasing electric vehicle production and building climate-resilient roads and bridges.

    Strategic National Stockpile, the country’s emergency medical reserve, for supplies and efforts to restructure it that began last year. Nearly $7 billion would create an agency meant to research diseases like cancer and diabetes.

    Reporting was contributed by Coral Davenport, Zolan Kanno-Youngs, Lisa Friedman, Brad Plumer, Christopher Flavelle, Mark Walker, Dana Goldstein, Mark Walker, Noah Weiland, Margot Sanger-Katz, Lara Jakes, Noam Scheiber, Katie Benner and Emily Cochrane.

    View Source